Budget Amount *help |
¥3,570,000 (Direct Cost: ¥3,000,000、Indirect Cost: ¥570,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2008: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2007: ¥1,100,000 (Direct Cost: ¥1,100,000)
|
Research Abstract |
We found that CD133 was expressed in several neuroblastoma (NB) cell lines/tumor samples. Intriguingly, CD133 repressed NB cell differentiation, accelerated cell proliferation, anchorage-independent colony formation, and in vivo tumor formation of NB cells. CD133-related differentiation suppression in NB was in part dependent on neurotrophic receptor RET tyrosine kinase regulation. RET transcription was suppressed by CD133 in NB cells and GDNF treatment failed to induce RET in CD133-expressing cells. CD133 in cancer cells and our findings may be applied to improve differentiation induction therapy for NB patients.
|